We are live on ! Find out more
MJRIC

Mogy Joel R Investment Counsel Portfolio holdings

AUM $1.75B
1-Year Est. Return 17.81%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+17.81%
3 Year Est. Return
+97.31%
5 Year Est. Return
+136.49%
10 Year Est. Return
+593.66%
AUM
$546M
AUM Growth
+$5.73M
Cap. Flow
-$6.48M
Cap. Flow %
-1.19%
Top 10 Hldgs %
34.78%
Holding
128
New
5
Increased
35
Reduced
38
Closed
4

Top Buys

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$4.56M
2
HD icon
Home Depot
HD
+$3.56M
3
META icon
Meta Platforms (Facebook)
META
+$3.51M
4
INTU icon
Intuit
INTU
+$1.7M
5
MA icon
Mastercard
MA
+$1.46M

Sector Composition

Rank Sector Weight
1 Technology 20.8%
2 Healthcare 17.01%
3 Communication Services 14.17%
4 Consumer Discretionary 12.92%
5 Consumer Staples 11.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZO icon
26
AutoZone
AZO
$49.7B
$8.07M 1.48%
10,505
-1,810
-15% -$1.41M
FNGN
27
DELISTED
Financial Engines, Inc.
FNGN
$7.44M 1.36%
250,391
+5,217
+2% +$152K
NKE icon
28
Nike
NKE
$60.1B
$7.13M 1.31%
135,344
+19,420
+17% +$1.1M
HSIC icon
29
Henry Schein
HSIC
$10.1B
$6.94M 1.27%
108,630
+10,136
+10% +$673K
UNP icon
30
Union Pacific
UNP
$174B
$6.02M 1.1%
61,768
-3,670
-6% -$343K
IDXX icon
31
Idexx Laboratories
IDXX
$45B
$5.76M 1.06%
51,080
PM icon
32
Philip Morris
PM
$290B
$5.25M 0.96%
53,957
-68
-0.1% -$6.81K
AGN
33
DELISTED
Allergan plc
AGN
$5.07M 0.93%
21,996
-422
-2% -$103K
PFE icon
34
Pfizer
PFE
$150B
$4.81M 0.88%
149,754
+293
+0.2% +$9.8K
INTC icon
35
Intel
INTC
$509B
$4.67M 0.86%
123,731
GILD icon
36
Gilead Sciences
GILD
$168B
$4.63M 0.85%
58,455
-12,200
-17% -$991K
ABBV icon
37
AbbVie
ABBV
$440B
$4.62M 0.85%
73,188
+122
+0.2% +$7.9K
MO icon
38
Altria Group
MO
$107B
$4.52M 0.83%
71,436
+151
+0.2% +$10K
INTU icon
39
Intuit
INTU
$91.6B
$4.39M 0.8%
39,880
+15,205
+62% +$1.7M
SPG icon
40
Simon Property Group
SPG
$71.4B
$4.24M 0.78%
20,469
-658
-3% -$143K
PANW icon
41
Palo Alto Networks
PANW
$315B
$4.11M 0.75%
154,860
+9,570
+7% +$218K
ORLY icon
42
O'Reilly Automotive
ORLY
$74.5B
$3.82M 0.7%
204,450
+72,375
+55% +$1.36M
MA icon
43
Mastercard
MA
$490B
$3.81M 0.7%
37,395
+15,200
+68% +$1.46M
BBBY
44
DELISTED
Bed Bath & Beyond Inc
BBBY
$3.41M 0.63%
79,100
-97,109
-55% -$4.32M
MRK icon
45
Merck
MRK
$328B
$3.25M 0.6%
54,621
+167
+0.3% +$9.77K
CVX icon
46
Chevron
CVX
$386B
$3.15M 0.58%
30,601
IBM icon
47
IBM
IBM
$222B
$3.07M 0.56%
20,190
ABT icon
48
Abbott
ABT
$192B
$3.06M 0.56%
72,247
+1,781
+3% +$76.3K
TROW icon
49
T. Rowe Price
TROW
$23.8B
$2.97M 0.54%
44,631
-2,169
-5% -$151K
TWX
50
DELISTED
Time Warner Inc
TWX
$2.96M 0.54%
37,186

Similar funds

Mogy Joel R Investment Counsel's Q3 2016 Portfolio in Review

As of Q3 2016, Mogy Joel R Investment Counsel held 128 positions worth $546M, up 1.1% from $540M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Mogy Joel R Investment Counsel's Q3 2016 filing shows 5 new, 35 increased, 38 reduced and 4 closed positions. Its largest new stake was Mead Johnson Nutrition Company: 4,895 shares worth $387K. The largest sale was Stericycle Inc, an estimated $9.19M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Communication Services.

  • Mogy Joel R Investment Counsel's largest Q3 2016 buy was Mead Johnson Nutrition Company: 4,895 shares worth $387K.
  • Mogy Joel R Investment Counsel added most to GE Aerospace in Q3 2016, an estimated $4.56M increase.
  • Mogy Joel R Investment Counsel's biggest Q3 2016 reduction was Bed Bath & Beyond Inc, cutting an estimated $4.32M.
  • Mogy Joel R Investment Counsel fully exited Stericycle Inc in Q3 2016, selling an estimated $9.19M.
  • Mogy Joel R Investment Counsel's ten largest holdings make up 35% of its $546M portfolio in Q3 2016.
  • Mogy Joel R Investment Counsel opened 5 new positions and closed 4 in Q3 2016.
  • Mogy Joel R Investment Counsel's portfolio value rose 1.1% quarter-over-quarter to $546M.

Based on Mogy Joel R Investment Counsel's 13F filing for Q3 2016, filed 7 Nov 2016.